Description of Medical Areas
About the FDA Approved Listings
|
 |
Drugs Approved by the FDA (1999)
|
The following drugs have been approved this year by
the Food and Drug Administration.
Cardiology/Vascular Diseases
|
|
Niaspan; Niacin extended-release tablets; Kos Pharmaceuticals; October 28, 1999
Dental/Maxillofacial Surgery
|
|
Atridox; Treatment of chronic adult periodontitis; Atrix Laboratories; Approved January 1999
Dermatology/Plastic Surgery
|
|
ACTOS; Treatment for type II diabetes; Takeda; Approved July 1999 Aggrenox; Aggrenox (aspirin/extended-release dipyridamole) 25mg/200mg capules for the prevention of recurrence of stroke; Boehringer Ingelheim; Approved November 1999 Aromasin Tablets; Exemestane Tablets, 25 mg; Pharmacia & Upjohn; October 21, 1999 Cernevit; For the treatment of vitamin deficiency; Baxter Healthcare; Approved April 1999. Climara; For the prevention of postmenopausal osteoporosis (loss of bone mass); Berlex Laboratories; Approved June 1999 Ellence; epirubicin hydrochloride; Pharmacia & Upjohn; Approved September 1999 Ethyol (amifostine); Treatment for xerostomia (dry mouth) due to radiation; U.S. Bioscience, Alza; Approved June 1999 Evista; Osteoporosis treatment; Eli Lilly; Approved September 1999 Femhrt Tablets; Norethindrone acetate (1mg) and ethinyl estradiol tablets (5mcg); Parke-Davis; October 15, 1999 Ortho-Prefest; 17 beta estradiol/17 beta estradiol norgestimate tablets; Ortho-McNeil Pharmaceutical, R.W. Johnson; October 22, 1999
Prevpac; Treatment for eradication of H. pylori; TAP Pharmaceuticals; Approved February 1999
Aggrenox; Aggrenox (aspirin/extended-release dipyridamole) 25mg/200mg capules for the prevention of recurrence of stroke; Boehringer Ingelheim; Approved November 1999 Busulflex; For use in combination for the treatment of leukemia; Orphan Medical; Approved February 1999 Ferrlecit; For the treatment of iron deficiency anemia.; R&D Laboratories; Approved February 1999 Fragmin; Treatment of prophylaxis of deep vein thrombosis (DVT); Pharmacia & Upjohn; Approved March 1999
Immunology/Infectious Diseases
|
|
Cleocin; Treatment for bacterial vaginosis; Pharmacia & Upjohn; Approved August 1999 Famvir; Treatment for Herpes Simplex Infections in HIV-infected patients; SmithKline Beecham; Approved January 1999 Panretin Gel; Treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma.; Ligand Pharmaceuticals; Approved June 1999 Rapamune; Oral solution of sirolimus; Wyeth-Ayerst Laboratories; Approved September 1999 Relenza; Treatment for uncomplicated acute illness due to influenza virus; GlaxoWellcome; Approved July 1999 Synercid I.V.; quinupristin and dalfopristin for injection; Rhone Poulenc Rorer; Approved September 1999 Vistide; For the treatment of cytomegalovirus (CMV) retinitis; Gilead Sciences; Approved March 1999
Evista; Osteoporosis treatment; Eli Lilly; Approved September 1999 Femhrt Tablets; Norethindrone acetate (1mg) and ethinyl estradiol tablets (5mcg); Parke-Davis; October 15, 1999
Levaquin; Treatment for urinary tract infection; R.W. Johnson; Approved July 1999 Tequin; Tequin (Injectable and Tablet); Bristol-Myers Squibb; December, 1999
Aggrenox; Aggrenox (aspirin/extended-release dipyridamole) 25mg/200mg capules for the prevention of recurrence of stroke; Boehringer Ingelheim; Approved November 1999 Cenestin; Treatment for symptoms associated with menopause; Duramed Pharmaceuticals; Approved July 1999 Comtan; 200mg entacapone tablets; Novartis; October 19, 1999 Keppra; Levetiracetam tablets for adjunctive treatment of partial onset seizures in adults with epilepsy; UCB Pharma; Approved November 1999 Sonata; Treatment fo insomnia; American Home Products; Approved August 1999 Topamax; Treatment for epilepsy in pediatric patients; Ortho-McNeil Pharmaceutical; Approved July 1999
Aromasin Tablets; Exemestane Tablets, 25 mg; Pharmacia & Upjohn; October 21, 1999 Cenestin; Treatment for relief of vasomotor symptoms due to menopause; Duramed Pharmaceuticals; Approved March 1999 Cenestin; Treatment for symptoms associated with menopause; Duramed Pharmaceuticals; Approved July 1999 Cleocin; Treatment for bacterial vaginosis; Pharmacia & Upjohn; Approved August 1999 Climara; For the prevention of postmenopausal osteoporosis (loss of bone mass); Berlex Laboratories; Approved June 1999 Ellence; epirubicin hydrochloride; Pharmacia & Upjohn; Approved September 1999 Estradiol Transdermal System; Transdermal patch system for the treatement of vulvar vaginal atrophy and vasomotor symptoms.; Wyeth-Ayerst Laboratories; Approved September 1999 Evista; Osteoporosis treatment; Eli Lilly; Approved September 1999 Femhrt Tablets; Norethindrone acetate (1mg) and ethinyl estradiol tablets (5mcg); Parke-Davis; October 15, 1999 Lupron Depot; Treatment for endometriosis and uterine fibroids; TAP Pharmaceuticals; Approved June 1999 Ortho-Prefest; 17 beta estradiol/17 beta estradiol norgestimate tablets; Ortho-McNeil Pharmaceutical, R.W. Johnson; October 22, 1999 Tequin; Tequin (Injectable and Tablet); Bristol-Myers Squibb; December, 1999
Aromasin Tablets; Exemestane Tablets, 25 mg; Pharmacia & Upjohn; October 21, 1999 Busulflex; For use in combination for the treatment of leukemia; Orphan Medical; Approved February 1999 Ellence; epirubicin hydrochloride; Pharmacia & Upjohn; Approved September 1999 Ethyol (amifostine); Treatment for xerostomia (dry mouth) due to radiation; U.S. Bioscience, Alza; Approved June 1999 Temodar; Treatment for refractory anaplastic astrocytoma; Schering-Plough; Approved August 1999 UVADEX Sterile Solution; Treatment of the skin manifestations of cutaneous T-cell lymphoma (CTCL); Therakos; Approved February 1999 Zofran ODT; Treatment for the prevention of chemotherapy and radiation-induced nausea; GlaxoWellcome; Approved January 1999
Alamast; pemirolast potassium ophthalmic solution; Santen; Approved September 1999 ZADITOR; Treatment for the prevention of itching of the eye; Ciba Vision; Approved July 1999
Ethyol (amifostine); Treatment for xerostomia (dry mouth) due to radiation; U.S. Bioscience, Alza; Approved June 1999
Amoxil (amoxicillin); Treatment (antibiotic) for common bacteria; SmithKline Beecham; Approved July 1999 Topamax; Treatment for epilepsy in pediatric patients; Ortho-McNeil Pharmaceutical; Approved July 1999
Raplon; Adjunct to general anesthesia during surgical procedures; Organon; Approved August 1999
Effexor; Treatment for generalized anxiety disorder; Wyeth-Ayerst Laboratories; Approved March 1999 Paxil CR Tablets; Treatment for depression; SmithKline Beecham; Approved March 1999 Sonata; Treatment fo insomnia; American Home Products; Approved August 1999
Pulmonary/Respiratory Diseases
|
|
Accolate; zafirlukast, 10 mg and 20 mg tablets.; AstraZeneca; Approved September 1999 Cafcit Injection; For the short term treatment of apnea of prematurity in infants between 28 and <33 weeks gestational age.; Roxane Laboratories; Approved September 1999 Tequin; Tequin (Injectable and Tablet); Bristol-Myers Squibb; December, 1999
Lodine XL; Treatment for the signs and symptoms of osteoarthritis and rheumatoid arthritis; Wyeth-Ayerst Laboratories; Approved May 1999
Trauma/Emergency Medicine
|
|
|
|
Back to Centerwatch Drug Directories
|
